OSE Pharma SA (OSE) — Cash Flow-to-Debt Ratio
OSE Pharma SA (OSE) has a Cash Flow-to-Debt Ratio of -0.34x as of June 2025, meaning its operating cash flow of €-17.98 Million could theoretically repay 0% of its total liabilities (€53.58 Million) in one year. See financial flexibility index of OSE Pharma SA to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
OSE Pharma SA Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for OSE Pharma SA across 13 annual periods. For the full cash flow conversion analysis, see OSE Pharma SA (OSE) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for OSE Pharma SA (2012–2024)
Year-by-year debt coverage analysis for OSE Pharma SA. Check OSE Pharma SA (OSE) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.81x | €48.44 Million | €60.15 Million | ▲ +340.7% |
| 2023 | -0.33x | €-19.76 Million | €59.08 Million | ▼ -8.4% |
| 2022 | -0.31x | €-18.25 Million | €59.12 Million | ▼ -68.0% |
| 2021 | -0.18x | €-9.92 Million | €53.99 Million | ▲ +66.5% |
| 2020 | -0.55x | €-19.55 Million | €35.61 Million | ▼ -286.0% |
| 2019 | 0.30x | €8.97 Million | €30.40 Million | ▲ +315.1% |
| 2018 | 0.07x | €1.08 Million | €15.15 Million | ▲ +119.5% |
| 2017 | -0.36x | €-8.00 Million | €21.91 Million | ▼ -1435.2% |
| 2016 | 0.03x | €684.00K | €25.02 Million | ▲ +101.5% |
| 2015 | -1.83x | €-4.61 Million | €2.52 Million | ▼ -163.2% |
| 2014 | -0.70x | €-1.94 Million | €2.78 Million | ▼ -253.9% |
| 2013 | -0.20x | €-236.00K | €1.20 Million | ▲ +87.1% |
| 2012 | -1.52x | €-1.39 Million | €915.00K | — |